JP Patent

JP5350369B2 — 乳癌治療および予後におけるｅｓｒコピー数変化の利用方法

Assigned to ダコ デンマーク アクティーゼルスカブ · Expires 2013-11-27 · 12y expired

What this patent protects

Patent listed against elacestrant-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP5350369B2
Jurisdiction
JP
Classification
—
Expires
2013-11-27
Drug substance claim
No
Drug product claim
No
Assignee
ダコ デンマーク アクティーゼルスカブ
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.